Zura Bio Limited
ZURA
$5.78
-$0.35-5.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 34.39M | 35.14M | 33.16M | 32.20M | 37.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 92.75M | 81.49M | 75.25M | 72.57M | 72.37M |
| Operating Income | -92.75M | -81.49M | -75.25M | -72.57M | -72.37M |
| Income Before Tax | -85.82M | -75.43M | -68.65M | -65.10M | -67.76M |
| Income Tax Expenses | -81.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -85.74 | -75.43 | -68.65 | -65.10 | -67.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -85.74M | -75.43M | -68.65M | -65.10M | -67.76M |
| EBIT | -92.75M | -81.49M | -75.25M | -72.57M | -72.37M |
| EBITDA | -92.69M | -81.44M | -75.20M | -72.53M | -72.34M |
| EPS Basic | -1.12 | -1.08 | -1.05 | -0.67 | -0.72 |
| Normalized Basic EPS | -0.50 | -0.47 | -0.46 | -0.44 | -0.47 |
| EPS Diluted | -1.12 | -1.08 | -1.05 | -0.67 | -0.72 |
| Normalized Diluted EPS | -0.50 | -0.47 | -0.46 | -0.44 | -0.47 |
| Average Basic Shares Outstanding | 428.41M | 395.89M | 376.63M | 372.77M | 365.54M |
| Average Diluted Shares Outstanding | 428.41M | 395.89M | 376.63M | 372.77M | 365.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |